Cronos (CRON) Income from Continuing Operations (2018 - 2026)
Cronos (CRON) recorded quarterly Income from Continuing Operations of 15711000.0 in Q1 2026, up 3299.8% quarter-over-quarter from 491000.0 in Q4 2025, and up 103.43% on a YoY basis from 7723000.0 in Q1 2025.
Cronos (CRON) Income from Continuing Operations (2018 - 2026) Analysis & Trends
Cronos' Income from Continuing Operations history runs 9 years deep, the most recent figure standing at 15711000.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations rose 103.43% year-over-year to 15711000.0; the TTM figure through Mar 2026 stood at 5059000.0 (down 89.93% YoY), while the FY2025 annual figure was 2929000.0, down 107.32% from the prior year.
- Income from Continuing Operations was 15711000.0 for Q1 2026 at Cronos, up from 491000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 43941000.0 in Q4 2024 to a low of 76181000.0 in Q4 2022.
- Historically, Income from Continuing Operations has averaged 10417705.88 across 5 years, with a median of 5663000.0 in 2023.
- The sharpest annual moves came in 2024 and 2025: Income from Continuing Operations jumped 560.63% in 2024, then sank 339.34% in 2025.
- A 5-year view of Income from Continuing Operations shows it stood at 76181000.0 in 2022, then soared by 40.73% to 45151000.0 in 2023, then jumped by 197.32% to 43941000.0 in 2024, then slumped by 101.12% to 491000.0 in 2025, then surged by 3299.8% to 15711000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 15711000.0 (Q1 2026), 491000.0 (Q4 2025), and 28321000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 370.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 21.05 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -66.53 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 118.42 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -92.12 Mn |
| 10 | Cronos | 1.06 Bn | 284.85 Mn | 19.15 Mn | 15.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.71 Mn |
| Dec 31, 2025 | -491,000.00 |
| Sep 30, 2025 | 28.32 Mn |
| Jun 30, 2025 | -38.48 Mn |
| Mar 31, 2025 | 7.72 Mn |
| Dec 31, 2024 | 43.94 Mn |
| Sep 30, 2024 | 7.32 Mn |
| Jun 30, 2024 | -8.76 Mn |
| Mar 31, 2024 | -2.48 Mn |
| Dec 31, 2023 | -45.15 Mn |
| Sep 30, 2023 | -1.59 Mn |
| Jun 30, 2023 | -5.66 Mn |
| Mar 31, 2023 | -18.04 Mn |
| Dec 31, 2022 | -76.18 Mn |
| Sep 30, 2022 | -33.11 Mn |
| Jun 30, 2022 | -17.53 Mn |
| Mar 31, 2022 | -32.65 Mn |
| Dec 31, 2021 | 134.73 Mn |
| Sep 30, 2021 | 77.58 Mn |
| Jun 30, 2021 | -178.79 Mn |